CXO

CXO has delivered first spodumene concentrate on schedule and within budget six months after FID, clearing a critical operational hurdle for Finniss restart with Q4 2026 shipment targeted. The achievement de-risks near-term cash generation but offers little new upside—it was the telegraphed milestone, not a surprise acceleration or higher-than-expected grades.

CXO has sold its final 25kt lithium fines stockpile to Glencore for ~A$10–11M net proceeds (at A$400/t base, minus grade/transport adjustments), completing a deliberate cash-generation strategy that has yielded A$38.5M in 2026 and strengthens runway into first spodumene concentrate shipment in Q4 2026. The sale is unconditional and operationally routine; the headline value lies in the de-risking of ramp-up logistics and Glencore relationship validation, not in the stockpile liquidation itself.